Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 127

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 127
---
 products currently in development and additional families of patents that may provide
supplementary protection for those products and further products.

<div align='center'>76</div>

Patents

As of March 10, 2025, our exclusively
owned patent portfolio includes thirty-four (34) issued patents, of which eight (8) are U.S. patents and twenty-six (26) are foreign patents,
with eighteen (18) of the twenty-six (26) foreign patents being nationally validated in certain European extension/validation states).
In addition, one U.S. patent application and two patent applications are pending. The claims of the owned patents and patent applications
below are directed toward various aspects of our family of products, methods of their manufacturing, delivery device and research programs.

| Effective     
 Filing Date   |     | Patent       
 No.          |     | Title                                                                        |     | Country                 |     | Product     |     | Type                 
 of patent protection |     | Expiry date   |
| Dec. 15, 2004 |     | US 8,007,774 |     | Matrix composed of a naturally-occurring protein backbone                    
 cross linked by a synthetic polymer and methods of generating and using same |     | USA                     |     | GelrinC     |     | Utility patent       |     | Dec. 31, 2025 |
| Dec. 15, 2004 |     | US 9,120,872 |     | Matrix composed of a naturally-occurring protein backbone                    
 cross linked by a synthetic polymer and methods of generating and using same |     | USA                     |     | GelrinC     |     | Utility patent       |     | Dec. 31, 2025 |
| Dec. 15, 2004 |     | US 8,858,925 |     | Pegylated fibrinogen precursor molecule                                      |     | USA                     |     | GelrinC     |     | Utility patent       |     | Jun. 28, 2025 |
| Jun. 21, 2007 |     | EP 1870115   |     | Immediate release compositions for treating tissue                           
 damages                                                                      |     | Germany, Spain, France, 
 United Kingdom, Italy   |     | GelrinC     |     | Utility patent       |     | Jun. 6, 2027  |
| Apr. 16, 2008 |     | US 9,624,259 |     | Compositions and methods for scaffold